Bicycle Therapeutics PLC reports results for the quarter ended in June - Earnings Summary

Bicycle Therapeutics

03/08/2023 14:22

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted
loss of $1.41​​ per share for the quarter ended in June. The
mean expectation of fifteen analysts for the quarter was for a
loss of $1.29 per share.
    * Revenue rose 160.3% to $11.40 million from a year ago;
analysts
expected $4.58 million. 
    * Bicycle Therapeutics PLC's reported EPS for the quarter
was a
loss of $1.41​.
    * The mean earnings estimate of analysts had fallen by
about 6.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Bicycle Therapeutics PLC shares had fallen by 9.2% this
quarter and lost 21.8% so far this year.
    * The company reported a quarterly loss of $42.6 million.
    * Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $50.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 01:21 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.29          -1.41          Missed
 Mar. 31 2023      -1.07          -1.30          Missed
 Dec. 31 2022      -1.06          -1.01          Beat
 Sep. 30 2022      -0.89          -0.96          Missed